Connect with us

Life Sciences

Genes & Cancer | Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors

BUFFALO, NY- December 16, 2022 – A new research paper was published in Genes & Cancer on December 2, 2022, entitled, “Systems biology network reveals…

Published

on

This article was originally published by BioEngineering

BUFFALO, NY- December 16, 2022 – A new research paper was published in Genes & Cancer on December 2, 2022, entitled, “Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors.”

Figure 3

Credit: 2022 Gradowski Farias da Costa do Nascimento et al.

BUFFALO, NY- December 16, 2022 – A new research paper was published in Genes & Cancer on December 2, 2022, entitled, “Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors.”

Tumor-associated inflammation and chromosomal aberrations can play crucial roles in cancer development and progression. In neuroblastoma (NB), the enzyme cyclooxygenase-2 (COX-2) is associated with copy number alterations on the long arm of chromosome 11 (Ch 11q), defining an aggressive disease subset. 

In this new retrospective study, researchers from Thatyanne Gradowski Farias da Costa do Nascimento, Mateus Eduardo de Oliveira Thomazini, Nilton de França Junior, Lisiane de Castro Poncio, Aline Simoneti Fonseca, Bonald Cavalcante de Figueiredo, Saulo Henrique Weber, Roberto Hirochi Herai, Lucia de Noronha, Luciane R. Cavalli, Bruno César Feltes, and Selene Elifio-Esposito from Pontifícia Universidade Católica do Paraná, Faculdades Pequeno Príncipe, Instituto Buko Kaesemodel (IBK), Georgetown University, and Federal University of Rio Grande do Sul included formalin-fixed paraffin-embedded tumor samples collected from nine patients during diagnosis at the pediatric Pequeno Principe Hospital, Curitiba, PR, Brazil, and post-chemotherapy (CT). 

“In the current study, we analyzed the COX-2 levels in NB tumor samples and correlated this expression with segmental chromosome aberrations. Using a pipeline of computational systems biology tools, we investigated the direct and indirect connections between PTGS2 and correlated aberrations to search for new insights on inflammation in the pathophysiology of high-risk NB.”

COX-2 expression was evaluated using immunohistochemistry and correlated with the genome profile of paired pre- and post-CT samples, determined by array comparative genomic hybridization. A systems biology approach elucidated the PTGS2 network interaction. The results showed positive correlations between pre-CT Ch 7q gain and COX-2 expression (ρ = 0.825; p-value = 0.006) and negative correlations between Ch 7q gain and Ch 11q deletion (ρ = −0.919; p-value = 0.0005). Three samples showed Ch 11q deletion and Ch 7q gain. Network analysis identified a direct connection between CAV-1 (Ch 7q) and COX-2 in NB tumors and highlighted the connection between amplified genes in Ch 7q and deleted ones in 11q. 

“The identification of hub-bottleneck-switch genes provides new biological insights into this connection between NB, tumorigenesis, and inflammation.”
 

Read the full research paper: DOI: https://doi.org/10.18632/genesandcancer.225  

Correspondence: Selene Elifio-EspositoEmail: selene.e@pucpr.br 

Keywords: pediatric cancer, inflammation, chromosomal aberration, interaction network, neuroblastoma
 

About Genes & Cancer: Genes & Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. In addition to publishing manuscripts that directly relate to these areas of research, Genes & Cancer also aims to attract papers in the areas of genomics, drug development and systems biology.

To learn more about Genes & Cancer, visit www.genesandcancer.com and connect with us on social media:=

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Instagram

 

For media inquiries, please contact: media@impactjournals.com.

 

Genes & Cancer Journal Office

6666 East Quaker Str., Suite 1C

Orchard Park, NY 14127

Phone: 1-212-659-5400

###


Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending